Figure 8.
Changes in CD20 mRNA in CLL cells after adding rituximab and plasma. Significant down-modulation is noted after 120 minutes. The average of 2 different experiments using samples from 2 different patients is presented here. Wilcoxon matched pairs test showed a significant difference (P = .04) between samples with rituximab alone and samples with rituximab and plasma.